93 related articles for article (PubMed ID: 20187715)
1. Comparative effects of carvedilol and lercanidipine on ultrafiltration and solute transport in CAPD patients.
Topal C; Erkoc R; Sayarlioglu H; Dogan E; Beyenik H
Ren Fail; 2009; 31(6):446-51. PubMed ID: 20187715
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
4. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
5. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
6. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis.
Yu XF; Zhou YF; Feng L; Zhang DL; Liu WH
Chin Med J (Engl); 2009 Dec; 122(24):2977-80. PubMed ID: 20137485
[TBL] [Abstract][Full Text] [Related]
7. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
Tinroongroj N; Jittikanont S; Lumlertgul D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the peritoneal equilibration test and ultrafiltration in patients with and without diabetes mellitus on continuous ambulatory peritoneal dialysis.
Chou MY; Kao MT; Lai MN; Chung SY
Am J Nephrol; 2006; 26(1):87-90. PubMed ID: 16543711
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin and body surface area are the strongest predictors of the peritoneal transport type.
Díaz-Alvarenga A; Abasta-Jimenez M; Bravo B; Gamba G; Correa-Rotter R
Adv Perit Dial; 1994; 10():47-51. PubMed ID: 7999863
[TBL] [Abstract][Full Text] [Related]
11. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
[TBL] [Abstract][Full Text] [Related]
12. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
Nakamoto H; Imai H; Kawanishi H; Nakamoto M; Minakuchi J; Kumon S; Watanabe S; Shiohira Y; Ishii T; Kawahara T; Suzuki H
Adv Perit Dial; 2001; 17():238-43. PubMed ID: 11510284
[TBL] [Abstract][Full Text] [Related]
13. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients.
Rojas-Campos E; Cortés-Sanabria L; Martínez-Ramírez HR; González L; Martín-del-Campo F; González-Ortiz M; Cueto-Manzano AM
Perit Dial Int; 2005; 25(6):576-82. PubMed ID: 16411525
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
Yasuda G; Yatsu K; Yamamoto Y; Hirawa N
Kidney Blood Press Res; 2012; 36(1):131-8. PubMed ID: 23095799
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical course of lercanidipine-associated cloudy effluent in continuous ambulatory peritoneal dialysis.
Hsiao PJ; Lin HW; Sung CC; Wang CW; Chu P; Lin SH
Clin Nephrol; 2010 Sep; 74(3):217-22. PubMed ID: 20860906
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
Szeto CC; Poon P; Szeto CY; Wong TY; Lai KB; Li PK
Am J Kidney Dis; 2002 May; 39(5):1061-7. PubMed ID: 11979351
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis and changes of peritoneal function in CAPD and APD patients].
Yokoyama K
Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):259-70. PubMed ID: 8196223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
